Hutch News

Hutch News

Stories tagged 'drug resistance'

Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 4, 2017

First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy; Fred Hutch hosts first-of-its-kind regional conference for science communicators; and Pathway that regulates organ size may also underlie tumors’ resistance to certain chemotherapy drugs.

View story >


Super drugs for superbugs: Creative ways to combat antibiotic resistance

New discoveries could overcome antibiotic development stalemate, stay ahead of bacteria’s steady march toward drug resistance

Jan. 15, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

New discoveries could overcome antibiotic development stalemate and stay ahead of bacteria’s steady march toward drug resistance.

View story >


How H1N1 flu escaped Tamiflu

Dennis Chao, Jesse Bloom and colleagues map global spread of mutated, drug-resistant influenza

Oct. 3, 2011

A recent Fred Hutchinson Cancer Research Center study on drug-resistant flu makes fact more compelling than fiction. In the new movie "Contagion," health experts scramble to get ahead of a flu-like pandemic as a drug-resistant virus quickly spreads, killing millions of people within days after they contract the illness.

View story >


Three-drug H. pylori therapy better for some than four

New results from large Latin American SWOG study contradict clinical trial findings in Europe and Asia; geographic variations in antibiotic resistance may validate different drug regimens for different populations

Aug. 1, 2011

A large clinical trial at seven sites across Latin America has found that a standard three-drug regimen for treating H. pylori is more effective in the population studied than either of two four-drug regimens that proved superior in studies in Europe and Asia.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.